The SASPiPhi Team
Dr Heather Fairhead, Director
Dr Heather Fairhead, Director
Dr Heather Fairhead, Director
Heather has over 25 years of experience in research and development of phage-based technologies, as the inventor of SASPject and as CEO of early stage biotech companies taking an antibacterial product into the clinic. Heather holds a First Class BSc (Hons) degree in Biotechnology from the University of Nottingham, UK, and a PhD in Molecular Microbiology from the University of Sheffield, UK.
Richard Nagle, Director
Dr Heather Fairhead, Director
Dr Heather Fairhead, Director
A true biotechnology entrepreneur, Richard Nagle has 25 years of experience building and delivering innovative therapeutic portfolios within the immunology, inflammation, wound healing and drug delivery arenas. He has a strong record as a CEO, Board Director and Chair from technology transfer to market in a number of successful biopharm
A true biotechnology entrepreneur, Richard Nagle has 25 years of experience building and delivering innovative therapeutic portfolios within the immunology, inflammation, wound healing and drug delivery arenas. He has a strong record as a CEO, Board Director and Chair from technology transfer to market in a number of successful biopharma companies, developing competitive therapeutic strategies and bringing new innovative molecules to the clinic.
Dr Anne Barnard, CTO
Dr Heather Fairhead, Director
Dr Neil Anderson, CSO
Anne is a molecular microbiologist with >25 years research experience in bacterial gene regulation and bacteriophage biology, having held post-doctoral research positions at the University of Cambridge, UK, the University of Birmingham, UK, and in industry. Anne holds a BA (Hons) in Natural Sciences and a PhD in Molecular Microbiology from the University of Cambridge, UK.
Dr Neil Anderson, CSO
Dr Neil Anderson, CSO
Dr Neil Anderson, CSO
Neil has a BSc in Biology (Genetics) from the University of Leicester and a PhD in Molecular Biology from the University of Cambridge UK. He has over 25 years of experience in small biotech companies covering areas including cancer diagnostics,
bacteriophage anti-infectives, drug production, assays and kit development.
Sarah Knightley, COO
Dr Neil Anderson, CSO
Sarah Knightley, COO
Sarah has over 25 years experience in administrative operations in a range of industries, including over 5 years in biotech. Sarah has a strong background in organizational and budget management, and in corporate governance. She ensures smooth running of the company, from office operations to coordinating cross-departmental activities, to support the company's strategic goals.
Andrew Armour, CFO
Dr Neil Anderson, CSO
Sarah Knightley, COO
Andrew is a Chartered Accountant with wide industry experience including healthcare, particularly in financial restructuring, equity fundraising and corporate acquisitions and disposals. Andrew was the Finance Director of Colchester Hospital where he led the strategic plan to consolidate services on one site. Before becoming an FD, he s
Andrew is a Chartered Accountant with wide industry experience including healthcare, particularly in financial restructuring, equity fundraising and corporate acquisitions and disposals. Andrew was the Finance Director of Colchester Hospital where he led the strategic plan to consolidate services on one site. Before becoming an FD, he spent 15 years in the advisory departments of Grant Thornton and Deloitte working on restructuring and corporate finance assignments.